- Home
- IMCC vs EVOK Comparison
IMCC vs EVOK Comparison
Compare IMCC & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- EVOK
- Stock Information
- Founded
- IMCC 1980
- EVOK 2007
- Country
- IMCC Israel
- EVOK United States
- Employees
- IMCC N/A
- EVOK N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- EVOK Health Care
- Exchange
- IMCC Nasdaq
- EVOK Nasdaq
- Market Cap
- IMCC 7.5M
- EVOK 7.1M
- IPO Year
- IMCC N/A
- EVOK 2013
- Fundamental
- Price
- IMCC $2.37
- EVOK $4.81
- Analyst Decision
- IMCC
- EVOK
- Analyst Count
- IMCC 0
- EVOK 0
- Target Price
- IMCC N/A
- EVOK N/A
- AVG Volume (30 Days)
- IMCC 16.9K
- EVOK 10.0K
- Earning Date
- IMCC 03-27-2025
- EVOK 03-13-2025
- Dividend Yield
- IMCC N/A
- EVOK N/A
- EPS Growth
- IMCC N/A
- EVOK N/A
- EPS
- IMCC N/A
- EVOK N/A
- Revenue
- IMCC $38,042,859.00
- EVOK $8,617,036.00
- Revenue This Year
- IMCC $22.59
- EVOK $97.35
- Revenue Next Year
- IMCC $32.86
- EVOK $99.52
- P/E Ratio
- IMCC N/A
- EVOK N/A
- Revenue Growth
- IMCC N/A
- EVOK 100.35
- 52 Week Low
- IMCC $1.41
- EVOK $3.54
- 52 Week High
- IMCC $8.10
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- IMCC 53.35
- EVOK 59.77
- Support Level
- IMCC $2.05
- EVOK $4.68
- Resistance Level
- IMCC $2.60
- EVOK $4.94
- Average True Range (ATR)
- IMCC 0.21
- EVOK 0.28
- MACD
- IMCC 0.02
- EVOK 0.06
- Stochastic Oscillator
- IMCC 58.31
- EVOK 73.58
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.